ERK: a double-edged sword in cancer. ERK-dependent apoptosis as a potential therapeutic strategy for cancer

R Sugiura, R Satoh, T Takasaki - Cells, 2021 - mdpi.com
The RAF/MEK/ERK signaling pathway regulates diverse cellular processes as exemplified
by cell proliferation, differentiation, motility, and survival. Activation of ERK1/2 generally …

Census and evaluation of p53 target genes

M Fischer - Oncogene, 2017 - nature.com
The tumor suppressor p53 functions primarily as a transcription factor. Mutation of the TP53
gene alters its response pathway, and is central to the development of many cancers. The …

Apoptosis and acute brain ischemia in ischemic stroke

D Radak, N Katsiki, I Resanovic… - Current vascular …, 2017 - ingentaconnect.com
Apoptosis may contribute to a significant proportion of neuron death following acute brain
ischemia (ABI), but the underlying mechanisms are still not fully understood. Brain ischemia …

Molecular mechanisms of apoptosis and roles in cancer development and treatment

S Goldar, MS Khaniani, SM Derakhshan… - Asian Pacific journal …, 2015 - koreascience.kr
Programmed cell death (PCD) or apoptosis is a mechanism which is crucial for all
multicellular organisms to control cell proliferation and maintain tissue homeostasis as well …

The National Cancer Institute ALMANAC: a comprehensive screening resource for the detection of anticancer drug pairs with enhanced therapeutic activity

SL Holbeck, R Camalier, JA Crowell… - Cancer research, 2017 - AACR
To date, over 100 small-molecule oncology drugs have been approved by the FDA.
Because of the inherent heterogeneity of tumors, these small molecules are often …

Survivin: A molecular biomarker in cancer

PK Jaiswal, A Goel, RD Mittal - Indian Journal of Medical …, 2015 - journals.lww.com
Survivin, a member of the inhibitor of apoptosis (IAP) protein family that inhibits caspases
and blocks cell death, is highly expressed in most cancers and is associated with a poor …

[HTML][HTML] Survivin and tumorigenesis: molecular mechanisms and therapeutic strategies

X Chen, N Duan, C Zhang, W Zhang - Journal of Cancer, 2016 - ncbi.nlm.nih.gov
Survivin is the smallest member of the inhibitor of apoptosis protein family, which has key
roles in regulating cell division and inhibiting apoptosis by blocking caspase activation …

Transcriptional regulation by p53

R Beckerman, C Prives - Cold Spring Harbor …, 2010 - cshperspectives.cshlp.org
Inactivation of p53 is critical for the formation of most tumors. Illumination of the key function
(s) of p53 protein in protecting cells from becoming cancerous is therefore a worthy goal …

Validating survivin as a cancer therapeutic target

DC Altieri - Nature Reviews Cancer, 2003 - nature.com
Acquisition of the ability to evade cellular suicide, or apoptosis, is one of the master switches
that contributes to cellular transformation and, ultimately, to invasive cancer. Much has been …

Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics

AC Mita, MM Mita, ST Nawrocki, FJ Giles - Clinical cancer research, 2008 - AACR
Survivin, a member of the family of inhibitor of apoptosis proteins, functions as a key
regulator of mitosis and programmed cell death. Initially, survivin was described as an …